KFF Health News chief Washington correspondent Julie Rovner discussed Affordable Care Act subsidies on Crooked Media’s What a Day on Dec. 10 and on Slate’s What Next on Dec. 9. Click here to hear Rovner on What a Day. Click here to hear Rovner on What Next. KFF Health News Washington health policy reporter Amanda
JAMA Oncology highlights disparities in race reporting and diversity in clinical trials in the cancer field.Along with their colleagues, Dr. Jonathan Loree, a medical oncologist and assistant professor at the University of British Columbia in Vancouver in Canada and Dr. Kanwal Raghav, an associate professor in the Department of Gastrointestinal Medical Oncology at The University…
ALPA PROD/ Shutterstock">Healthy working life expectancy is the average number of years people in a population are likely to be healthy and in paid work from age 50. ALPA PROD/ ShutterstockIn 1800, the global average life expectancy was only 29 years. Today, life expectancy continues to rise, with babies born in the UK in 2018…
Share on PinterestExisting evidence suggests that Black and South Asian individuals are more likely to experience poor COVID-19 outcomes than other demographics.Several recent studies and reports from different countries have shown that Black, Asian, and minority ethnic individuals in the United States and Europe are more likely to experience poor outcomes if they contract SARS-CoV-2,…
Harvest Inc., an Arizona-based marijuana conglomerate, said on Tuesday it would appeal Pennsylvania’s decision to revoke the permit of an affiliated cannabis grower that was effectively put out of business for not following the most basic security regulations. The action Monday by the Pennsylvania Department of Health marked the first time that the agency has…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.